Pfizer, Inc. Press Releases

PFE 
$30.5
*  
0.08
0.26%
Get PFE Alerts
*Delayed - data as of Sep. 19, 2014 10:38 ET  -  Find a broker to begin trading PFE now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    PFE Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Pfizer Foundation Provides $2 Million In Grants To Support ‘Last-Mile’ Vaccine Coverage In Africa
9/19/2014 8:00:00 AM - Business Wire

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
9/3/2014 10:00:00 AM - Business Wire

Secondary Analysis of AMPLIFY-EXT Examining Predictors of Hospitalization Presented at ESC Congress: Eliquis (apixaban) Significantly Reduced the Risk of All-Cause Hospitalization Versus Placebo in Patients with Venous Thromboembolism (VTE)
8/30/2014 5:15:00 AM - Business Wire

InnoPharma Announces FDA Approval of Decitabine for Injection, a Generic Version of DACOGEN®
8/29/2014 10:13:00 AM - PR Newswire

Pfizer and Protalix BioTherapeutics Announce FDA Approval of Pediatric Indication for ELELYSO™ (taliglucerase alfa) for Injection, for Intravenous Use for the Treatment of Type 1 Gaucher Disease
8/28/2014 1:15:00 PM - Business Wire

Pfizer’s Investigational Vaccine Candidate for Clostridium difficile Receives U.S. Food and Drug Administration Fast Track Designation
8/28/2014 8:00:00 AM - Business Wire

Pfizer And Merck To Collaborate On Study Evaluating Novel Anti-Cancer Combination Regimen
8/26/2014 8:00:00 AM - Business Wire

Multimedia assets now available: ViiV Healthcare receives FDA approval for Triumeq® (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection
8/25/2014 9:00:00 AM - PR Newswire

ViiV Healthcare receives FDA approval for Triumeq® (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection
8/22/2014 3:46:00 PM - PR Newswire

U.S. FDA Approves Eliquis (apixaban) for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and for the Reduction in the Risk of Recurrent DVT and PE Following Initial Therapy
8/21/2014 1:31:00 PM - Business Wire

Palbociclib Expanded Access Program Now Open To Eligible U.S. Patients With HR+, HER2- Advanced Breast Cancer
8/21/2014 8:00:00 AM - Business Wire

Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution
8/21/2014 7:00:00 AM - PR Newswire

Bristol-Myers Squibb and Pfizer to Present New Data on Eliquis® (apixaban) at the ESC Congress 2014
8/20/2014 8:00:00 AM - Business Wire

Pfizer Announces Submission of Palbociclib New Drug Application to the FDA
8/18/2014 8:00:00 AM - Business Wire

Pfizer Announces FDA Acceptance Of And Priority Review Designation For Biologics License Application For Investigational Meningococcal B Vaccine
8/14/2014 5:01:00 PM - Business Wire

Nodality, Inc. Expands Intellectual Property Estate, Announces U.S. Patent for Broadly Enabling Single Cell Network Profiling (SCNP) Technology Platform
8/14/2014 8:00:00 AM - Business Wire

Advisory Committee on Immunization Practices Votes to Recommend Pfizer’s Prevnar 13® Vaccine in Adults Aged 65 Years and Older
8/13/2014 5:42:00 PM - Business Wire

RiverVest Venture Partners’ Otonomy Completes $100 Million Initial Public Offering
8/13/2014 10:23:00 AM - Business Wire

Pfizer Reports Top-line Results from Postherpetic Neuralgia and Painful Diabetic Peripheral Neuropathy Lyrica® Studies Conducted in China
8/12/2014 5:01:00 PM - Business Wire

23andMe Announces Agreement with Pfizer Inc. to Research Genetics of Ulcerative Colitis and Crohn's Disease
8/12/2014 9:00:00 AM - PR Newswire

European Medicines Agency Accepts Application Seeking New Indication For Prevenar 13®1 For Prevention Of Pneumococcal Pneumonia In Adults
8/7/2014 8:00:00 AM - Business Wire

Nodality Expands Senior Leadership Team, Appoints Kathleen LaPorte as Chief Business Officer
8/6/2014 8:00:00 AM - Business Wire

Pain Therapeutics Reports Q2 2014 Financial Results
8/5/2014 8:00:00 AM - GlobeNewswire

Rascal Flatts Joins the Thousands of People Who Choose Nexium® 24HR Every Day for Their Frequent Heartburn
8/4/2014 8:00:00 AM - Business Wire

InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada
7/30/2014 10:33:00 AM - PR Newswire